Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overgrowth Syndrome”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Post-approval studies (Phase 4)Study completedNCT04627337
What this trial is testing

Efficacy and Safety of Saccharomyces Boulardii in the Treatment of Small Intestinal Bacterial Overgrowth

Who this might be right for
Irritable Bowel Syndrome
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno 71
Testing effectiveness (Phase 2)Study completedNCT00975819
What this trial is testing

Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies

Who this might be right for
Kaposiform HemangioendotheliomasTufted AngiomaCapillary Venous Lymphatic Malformation+6 more
Denise Martin Adams 61
Early research (Phase 1)Study completedNCT02594215
What this trial is testing

Dose Finding Trial of MK-7075 in Children and Adults With Proteus Syndrome

Who this might be right for
Proteus Syndrome
National Human Genome Research Institute (NHGRI) 6
Not applicableActive Not RecruitingNCT06642051
What this trial is testing

Safety of the Sonablate HIFU System for the Ablation of Incompetent Veins of the Periphery

Who this might be right for
Chronic Venous Insufficiency, CVIVenous MalformationsVenous Leg Ulcers+3 more
Sonablate 30
Post-approval studies (Phase 4)Not Yet RecruitingNCT07426705
What this trial is testing

Effect of Multispecies Probiotic Supplementation on the Efficacy of Rifaximin α Therapy in Patients With Small Intestinal Bacterial Overgrowth (SIBO): a Randomized Placebo-controlled Trial

Who this might be right for
Small Intestinal Bacterial Overgrowth Syndrome (SIBO)IBS
Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji 100
Not applicableStudy completedNCT02204891
What this trial is testing

Probiotics in Intestinal Bacterial Overgrowth

Who this might be right for
Irritable Bowel Syndrome
University of Athens 26
Not applicableLooking for participantsNCT03050268
What this trial is testing

Familial Investigations of Childhood Cancer Predisposition

Who this might be right for
Acute LeukemiaAdenomatous PolyposisAdrenocortical Carcinoma+43 more
St. Jude Children's Research Hospital 1,500
Not applicableLooking for participantsNCT06710067
What this trial is testing

Urine Metabolites in the Diagnosis of Disease

Who this might be right for
Colorectal CancerSmall Intestinal Bacterial Overgrowth Syndrome (SIBO)Crohn Disease+1 more
Luventix, Inc. 1,250
Not applicableNot Yet RecruitingNCT05953857
What this trial is testing

Knowing and Treating Kosaki/Penttinen Syndromes

Who this might be right for
Kosaki Overgrowth SyndromePenttinen Syndrome
Centre Hospitalier Universitaire Dijon 30
Not applicableLooking for participantsNCT03001180
What this trial is testing

Identification of Biomarkers for Patients with Vascular Anomalies

Who this might be right for
Vascular AnomalyGeneralized Lymphatic AnomalyKaposiform Hemangioendothelioma+4 more
Children's Hospital Medical Center, Cincinnati 1,000
Large-scale testing (Phase 3)UnknownNCT04542473
What this trial is testing

Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children

Who this might be right for
SEPSISMALNUTRITION, CHILD
University of Oxford 400
Not applicableLooking for participantsNCT02399527
What this trial is testing

Lymphatic Anomalies Registry for the Assessment of Outcome Data

Who this might be right for
Lymphatic MalformationGeneralized Lymphatic Anomaly (GLA)Central Conducting Lymphatic Anomaly+7 more
Boston Children's Hospital 1,000
Not applicableStudy completedNCT06223685
What this trial is testing

The Efficacy of Probiotics as an Adjunct to Treatment of SIBO With Rifaximin

Who this might be right for
Irritable Bowel SyndromeSmall Intestinal Bacterial OvergrowthSIBO
Pomeranian Medical University Szczecin 129
Testing effectiveness (Phase 2)Study completedNCT06806319
What this trial is testing

Assessment of Growth Factors Levels Associated with Wound Healing After Soft Tissue Crown Lengthening

Who this might be right for
Gingival Overgrowth
Al-Azhar University 80
Not applicableStudy completedNCT04981262
What this trial is testing

Improved Quality of Life in Children With Intestinal Failure

Who this might be right for
Intestinal Pseudo-ObstructionShort Bowel SyndromeMalabsorption Syndrome Autoimmune Enteropathy+1 more
Oslo University Hospital 56
Not applicableStudy completedNCT03261856
What this trial is testing

Clinical Utility of Breath Tests in GI

Who this might be right for
Small Intestinal Bacterial OvergrowthLactose IntoleranceFructose Intolerance+1 more
Augusta University 1,080
Not applicableUnknownNCT02565654
What this trial is testing

Efficacy of Rifaximin to Treat Diarrhea-predominant Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
First Affiliated Hospital, Sun Yat-Sen University 120
Not applicableStudy completedNCT02872961
What this trial is testing

SIBO, Immune Activation, and FGIDs in Children

Who this might be right for
Small Intestinal Bacterial OvergrowthIrritable Bowel SyndromeFunctional Dyspepsia+1 more
The University of Texas Health Science Center, Houston 54
Not applicableNo Longer AvailableNCT03317366
What this trial is testing

Expanded Access to Provide ARQ 092 for the Treatment of Overgrowth Diseases and/or Vascular Anomalies

Who this might be right for
Proteus SyndromePIK3CA-Related Overgrowth Spectrum (PROS)Growth Disorders
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Testing effectiveness (Phase 2)Study completedNCT00259155
What this trial is testing

Rifaximin for the Treatment of Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
Cedars-Sinai Medical Center 92
Load More Results